miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression
- 28 May 2026
- journal article
- Published by Springer Nature in Human Cell
- Vol. 39 (6)
Abstract
Global cancer data show a continuous rise in cervical cancer incidence and mortality, burdening public health. To effectively mitigate this challenge, elucidating molecular pathogenesis and novel drug targets are critical for advancing clinical care. In this study, abnormally expressed miRNAs in cervical cancer were identified through TCGA data analysis. Expression levels were quantified using qRT-PCR and Western Blot, at both mRNA and protein levels, respectively. miR-141-5p and ACVRL1's interaction was validated with dual-luciferase assays. Cell behavior was evaluated using assays including CCK-8 assay. In vivo tumor growth was assessed in nude mice xenograft model. Database screening and subsequent validation using cancer cell lines and clinical samples revealed aberrantly elevated expression of miR-141-5p in cervical cancer. High expression of miR-141-5p in SiHa/HeLa cells significantly promoted cellular proliferation, migration, and invasion while concurrently inhibiting apoptosis, whereas its downregulation elicited opposing effects. ACVRL1 was identified as a direct target of miR-141-5p. Overexpressing miR-141-5p markedly upregulated ACVRL1 mRNA and protein levels, while its knockdown significantly reduced ACVRL1 expression at both mRNA and protein levels. Further functional analysis showed that ACVRL1 knockdown significantly impaired cellular proliferation, migration, and invasion while enhancing apoptosis in cervical cancer cells. Rescue experiments confirmed that miR-141-5p exerted regulatory effects on these cellular behaviors, at least partially through ACVRL1. miR-141-5p downregulation significantly suppressed tumor growth in vivo, as evidenced by reduced tumor volume and weight in nude mice. In brief, this study shows that miR-141-5p upregulation in cervical cancer promotes tumor progression via ACVRL1 regulation, indicating its potential in precision oncology.Keywords
Funding Information
- Natioanl Natural Science Foundation of China (82272622)
This publication has 23 references indexed in Scilit:
- Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervixScientific Reports, 2025
- Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery systemScientific Reports, 2025
- Paradigm shift: microRNAs interact with target gene promoters to cause transcriptional gene activation or silencingExperimental Cell Research, 2024
- Exploring treatment options in cancer: tumor treatment strategiesSignal Transduction and Targeted Therapy, 2024
- microRNAs in action: biogenesis, function and regulationNature Reviews Genetics, 2023
- microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancerJournal of Cellular Physiology, 2019
- The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesionsAntiviral Research, 2019
- The role of human papillomavirus vaccines in cervical cancer: Prevention and treatmentCritical Reviews in Oncology/Hematology, 2018
- Human papillomavirus and cervical cancerThe Lancet, 2013
- MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancerCancer, 2010